RAPT Therapeutics Inc. (RAPT)
1.05
-0.09 (-7.89%)
At close: Mar 03, 2025, 3:59 PM
1.05
-0.47%
After-hours: Mar 03, 2025, 04:00 PM EST
RAPT Therapeutics Balance Sheet Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Cash & Equivalents | 47.48M | 38.95M | 24.03M | 24.92M | 77.38M | 63.8M | 47.52M |
Short-Term Investments | 111.38M | 210.12M | 165.63M | 86.59M | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 598K | 605K |
Other Long-Term Assets | 3.87M | 4.04M | 2.92M | 389K | 389K | -209K | -369K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 2.92M | 3.63M | 6.64M | 8.18M | 6.25M | 1.26M | 725K |
Total Current Assets | 161.78M | 252.69M | 192.97M | 115.6M | 80.51M | 65.06M | 48.24M |
Property-Plant & Equipment | 7.68M | 9.48M | 2.74M | 2.98M | 3.71M | 4.16M | 1.91M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 11.55M | 13.52M | 5.66M | 3.37M | 4.1M | 4.55M | 2.15M |
Total Assets | 173.33M | 266.21M | 198.64M | 118.97M | 84.6M | 69.61M | 50.39M |
Account Payables | 5.18M | 3.37M | 2M | 2.38M | 1.14M | 1.77M | 1.11M |
Deferred Revenue | n/a | n/a | 1.02M | 4.1M | 4M | n/a | n/a |
Short-Term Debt | 2.45M | 4.34M | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 14.21M | 6.52M | 6.58M | 5.26M | 4.11M | 2.87M | 2.14M |
Total Current Liabilities | 21.84M | 14.22M | 9.6M | 11.74M | 9.26M | 4.64M | 3.25M |
Long-Term Debt | 4.46M | 6.82M | n/a | n/a | n/a | n/a | 108.64M |
Other Long-Term Liabilities | n/a | n/a | 2.15M | 2.19M | 2.23M | 969K | 905K |
Total Long-Term Liabilities | 4.46M | 6.82M | 2.66M | 3.05M | 2.23M | 969K | 109.55M |
Total Liabilities | 26.29M | 21.04M | 12.26M | 14.79M | 11.48M | 5.61M | 112.8M |
Total Debt | 6.91M | 8.99M | n/a | n/a | n/a | 161.11M | 108.64M |
Common Stock | 3K | 3K | 3K | 2K | 2K | 2K | 1K |
Retained Earnings | -484.68M | -367.88M | -284.05M | -214.84M | -161.95M | -118.95M | -82.81M |
Comprehensive Income | 103K | -26K | -206K | -177K | 20K | -4K | -3.77M |
Shareholders Equity | 147.03M | 245.17M | 186.38M | 104.18M | 73.12M | 64M | -62.41M |
Total Investments | 111.38M | 210.12M | 165.63M | 86.59M | n/a | 598K | 605K |